Detected ·
Retension Pharmaceuticals
—Other
Retension Pharmaceuticals priced its IPO at $12 per share, with shares beginning to trade on Nasdaq under ticker $RTSN, funding continued development of RTN-001 for resistant hypertension.
- linkedin.com/company/104353902
- Amount
- —
- Stage
- Other
- Event
- Funding round
- Detected
- 2026-10-21 04:04:00 UTC
- Signal ID
- e748fa18-ffe6-45fa-9574-a212a743edb0
As the API returns it
{
"id": "e748fa18-ffe6-45fa-9574-a212a743edb0",
"created_at": "2026-10-21T04:04:00.504995Z",
"company_name": "Retension Pharmaceuticals",
"company_website_url": "www.retensionpharmaceuticals.com",
"company_linkedin_url": "https://www.linkedin.com/company/104353902",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": "other",
"message": "*Retension Pharmaceuticals priced its IPO at $12 per share, with shares beginning to trade on Nasdaq under ticker $RTSN, funding continued development of RTN-001 for resistant hypertension.*"
}